Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04930328 · ClinicalTrials.gov registry record
Retrospective Real World Oxbryta® Data Collection and Analysis Study
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 216
- Enrollment target
NCT04930328 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 216 participants.
The verdict
NCT04930328 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 216 participants
- Enrollment target
Study Summary
The aim of this study is to collect and analyze retrospective data on Oxbryta in a real-world setting. This is a multicenter, retrospective data collection and analysis study to characterize health outcomes in approximately 300 patients with SCD who have been treated with Oxbryta as part of their usual care. Any patient with SCD who received Oxbryta treatment for at least 2 weeks as part of their usual care according to the Oxbryta US Prescribing Information (USPI) is eligible to participate. Study data from 1 year before and up to 1 year after the first dose of Oxbryta will be entered in case report forms (CRFs) via an electronic data capture (EDC) system by the study staff.
Interventions
- DRUG Oxbryta® (voxelotor) 500-mg Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2021-03-20 |
| Est. Completion | 2022-02-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04930328
The ClinicalTrials.gov registry entry for NCT04930328 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxbryta® (voxelotor) 500-mg Tablets is the first listed.
NCT04930328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04930328 about?
NCT04930328 is a clinical study titled "Retrospective Real World Oxbryta® Data Collection and Analysis Study". The aim of this study is to collect and analyze retrospective data on Oxbryta in a real-world setting. This is a multicenter, retrospective data collection and analysis study to characterize health outcomes in approximately 300 patients with SCD who have been treated with Oxbryta as part of their us...
What is the current status of trial NCT04930328?
This trial is currently completed. The enrollment target is 216 participants. The study started on 2021-03-20. Estimated completion is 2022-02-25.
What interventions are being tested in trial NCT04930328?
The interventions under investigation include: Oxbryta® (voxelotor) 500-mg Tablets (DRUG).
Who is sponsoring clinical trial NCT04930328?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.